Barclays »

Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Barclays

Quarter-by-quarter ownership of Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Neurocrine Biosciences Inc Note 2.250 5/1

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences Inc Note 2.250 5/1 held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences Inc Note 2.250 5/1 by Barclays

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.2M 680k 1.80
2023-12-31 $974k 562k 1.73
2023-09-30 $705k 475k 1.48
2023-06-30 $186k 146k 1.27
2023-03-31 $120k 89k 1.35
2022-12-31 $1.1M 685k 1.57
2022-09-30 $731k 522k 1.40
2022-06-30 $619k 465k 1.33
2022-03-31 $514k 397k 1.29
2021-12-31 $921k 743k 1.24
2021-09-30 $29k 22k 1.32
2021-06-30 $452k 340k 1.33
2021-03-31 $405k 299k 1.35
2020-12-31 $2.5M 1.8M 1.38
2020-09-30 $12M 8.4M 1.38
2020-03-31 $2.2M 1.7M 1.28
2019-09-30 $0 1.4M 0.00
2018-12-31 $13M 11M 1.19
2018-09-30 $6.4M 3.8M 1.70
2018-06-30 $870k 604k 1.44